Type I interferon in anti-MDA5 dermatomyositis, S.H. Zhang et al.

5:27   Interview with Dr. Mark McPherson- Management of MDA-5 ILD 5:32   COVID-19 Triggered Anti-MDA-5 Antibody: Innocent Bystander or Culprit? Dr. Smarika Saptoka at RWCS22 2:25   Understanding TIF1‑γ and MDA5 Antibodies in Dermatomyositis | Antibody Series Part 1 6:31   Video Abstract: Long-Term Prognosis of anti-MDA5–Positive DM-ILD 11:01   Diagnosis : Anti-synthetases syndrome and anti-MDA5 dermatomyositis (Part 1/2) 11:13   Anti-MDA5 Antibody for Diagnosis and Prognosis of DM with ILD: Webinar by Dr. Ran Nakashima 0:20   COVID-19 pandemic caused surge in MDA5 disease 10:29   Lung Disease in Rare Autoimmune Conditions 1:37   抗MDA5抗体陽性皮膚筋炎に合併する間質性肺炎にJAK阻害薬 1:10   MDA5抗體陽性患者，也有治療成功的案例 2:00   Anti MDA5 Dermatomyositis 1:58   Paediatric Rheumatology- Rare MDA5 4:56   Anti-MDA-5 Antibody Dermatomyositis